Clinical Trials Logo

Clinical Trial Summary

After onset of Acute Ischemic Stroke (AIS), every minute of delay to treatment reduces the likelihood of a good clinical outcome. A key delay occurs in the time between completion of computed tomography (CT) angiography of the head and neck and interpretation in the setting of AIS care. The purpose of this study is to assess the effect of incorporating Viz.AI software, which via via a machine-learning algorithm performs artificial intelligence-based automated detection of large vessel occlusions (LVO) on CT angiography (CTA) images and alerts the AIS care team (diagnosis and treatment decisions will be based on the clinical evaluation and review of the images by the treating physician, per routine standard of care). The hypothesis is that integration of the software into the AIS care pathway will reduce delays in treatment. A cluster-randomized stepped-wedge trial will be performed across 4 hospitals in the greater Houston area.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05838456
Study type Interventional
Source The University of Texas Health Science Center, Houston
Contact
Status Completed
Phase N/A
Start date January 1, 2021
Completion date May 27, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05585606 - Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke Phase 2
Completed NCT00821821 - Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke Phase 2